Podcast Exclusive: Jeff Shuren Discusses FDA's Device Strategic Priorities

In an exclusive sit-down with Medtech Insight, CDRH Director Jeff Shuren talked about his priorities for his center over the next three years and how they could impact the medical device industry. The overall aim is to boost the number of novel medical devices that reach the US market first.

Exclusive interview Q&A KOI

More from Regulation

More from Policy & Regulation